2021
DOI: 10.1128/spectrum.00816-21
|View full text |Cite
|
Sign up to set email alerts
|

Shared Mutations in Emerging SARS-CoV-2 Circulating Variants May Lead to Reverse Transcription-PCR (RT-PCR)-Based Misidentification of B.1.351 and P.1 Variants of Concern

Abstract: Reverse transcription-PCRs (RT-PCRs) targeting SARS-CoV-2 variant of concern (VOC) mutations have been developed to simplify their tracking. We evaluated an assay targeting E484K/N501Y to identify B.1.351/P1. Whole-genome sequencing (WGS) confirmed only 72 (59.02%) of 122 consecutive RT-PCR P.1/B.1.351 candidates. Prescreening RT-PCRs must target a wider set of mutations, updated from WGS data from emerging variants.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Phylodynamic reconstruction indicated a high level of variability with an exponential growth of lineages until May-June 2021 [8,9]. Subsequent Variants of Concern (VOCs), such as B.1.351 (β) and P.1 (γ), first identified in South Africa and Brazil, respectively [10], were primarily characterized by mutations E484K and N501Y [11]. They exhibited heightened contagion and resistance to neutralization by antibodies from convalescent and vaccine-recipient individuals, raising concerns, including issues related to misidentification due to shared mutations [12].…”
Section: First Lineages and First Variantsmentioning
confidence: 99%
“…Phylodynamic reconstruction indicated a high level of variability with an exponential growth of lineages until May-June 2021 [8,9]. Subsequent Variants of Concern (VOCs), such as B.1.351 (β) and P.1 (γ), first identified in South Africa and Brazil, respectively [10], were primarily characterized by mutations E484K and N501Y [11]. They exhibited heightened contagion and resistance to neutralization by antibodies from convalescent and vaccine-recipient individuals, raising concerns, including issues related to misidentification due to shared mutations [12].…”
Section: First Lineages and First Variantsmentioning
confidence: 99%